NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.
Shares of Viatris Inc. VTRS slid 2.81% to $8.98 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 1.39% to 5,521.52 and Dow ...
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at generic pharmaceuticals stocks, starting ...
Shares of Viatris Inc. VTRS slipped 1.07% to $9.24 Wednesday, on what proved to be an all-around mixed trading session for ...
I n times of uncertainty and market volatility, many investors seek the dependability of owning high-dividend stocks. Regular dividends help temper the ups and downs of the market ...
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN VIATRIS INC. (VTRS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
Barclays 27th Annual Global Healthcare Conference Call March 11, 2025 2:00 PM ETCompany ParticipantsScott Smith - Chief ...
AI stocks rebounded on Tuesday as American and Canadian officials backed off threats to escalate the two countries’ trade war ...
StockStory.org on MSN3d
1 Healthcare Stock to Target This Week and 2 to Turn DownPersonal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...
Viatris issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods. The most recent guidance for Viatris (VTRS) was reported ...
We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results